Trial Profile
Occupational Exposure to Human Papilloma Virus (HPV) and Prophylactic Vaccination (Version IV Dated 24Oct2017)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 23 Feb 2023
Price :
$35
*
At a glance
- Drugs V 503 (Primary)
- Indications Human papillomavirus infections
- Focus Pharmacodynamics
- 16 Feb 2023 Planned End Date changed from 30 Dec 2021 to 30 Dec 2023.
- 16 Feb 2023 Planned primary completion date changed from 30 Dec 2021 to 30 Dec 2023.
- 17 Aug 2021 Planned End Date changed from 15 Nov 2021 to 30 Dec 2021.